• Western blot analysis of lysates from 293 cells, using QORX Antibody. The lane on the right is blocked with the synthesized peptide.
  • Western blot analysis of various cells using PIG3 Polyclonal Antibody

Anti-TP53I3 antibody (241-290 aa) (STJ95088)

SKU:
STJ95088

Current Stock:
Host: Rabbit
Applications: WB/IHC/IF/ELISA
Reactivity: Human/Rat/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Quinone oxidoreductase PIG3 (241-290 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
IHC 1:100-1:300
ELISA 1:20000
IF 1:50-200
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: TP53I3
Gene ID: 9540
Uniprot ID: QORX_HUMAN
Immunogen Region: 241-290 aa
Specificity: PIG3 Polyclonal Antibody detects endogenous levels of PIG3 protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human QORX at the amino acid range 241-290
Protein Name Quinone Oxidoreductase Pig3
Nadph -Quinone Reductase Pig3
Tumor Protein P53-Inducible Protein 3
Protein Pig3
P53-Induced Gene 3 Protein
Database Links Reactome: R-HSA-6803205
Alternative Antibody Names Anti-Quinone Oxidoreductase Pig3 antibody
Anti-Nadph -Quinone Reductase Pig3 antibody
Anti-Tumor Protein P53-Inducible Protein 3 antibody
Anti-Protein Pig3 antibody
Anti-P53-Induced Gene 3 Protein antibody
Anti-TP53I3 antibody
Anti-PIG3 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance